Working at Peter MacCallum Cancer Centre company profile and information | SEEK

While at the Peter MacCallum Cancer Centre in Melbourne, the Governor-General spoke with Chief Executive Officer Professor Jason Payne, Medical Oncologist Dr Wanda Cui, and Professor Paul James about their lifesaving work. From understanding the genetic risks associated with a breast cancer diagnosis to exploring the post-treatment impacts on quality of life, their research — made possible through grants such as the Medical Research Future Fund (MRFF) — ensures that care remains central througho

Peter MacCallum Cancer Centre | LinkedIn

This Friday is World Cancer Day. It is a time to reflect on the impact of cancer. With your help, we can reduce that impact. Our dedicated cancer researchers are determined to discover cancer cures and develop more effective treatments with fewer side effects. Together we can make a difference in the fight against cancer. Donate today at donate.petermac.org.au/ | Peter MacCallum Cancer Foundation

Algorae pharmaceuticals partners with Peter MacCallum Cancer Centre for second AI-driven drug synergy screening program

RMH and Peter MacCallum Cancer Foundation neuro-oncologist Professor Mark Rosenthal has seen how devastating brain cancer can be to patients and loved ones. Working tirelessly in brain cancer research, he's unfortunately seen only two new drugs come out to combat brain cancer in his 20 year career. In this video, he speaks about the Brain Cancer Centre's new, innovative approach, bringing together some of the brightest minds in the research and clinical space. "The Brain Cancer Centre offers a s

New Peter Mac research out today in the journal Cell has revealed a new way to kill cancer cells in acute myeloid leukaemia (AML), one of the most aggressive and hard-to-treat blood cancers. The team from the Kats Lab found that AML cells — especially the stem cells that drive relapse — rely on a common molecule called heme to survive and multiply. When this process is blocked, the hashtag#cancer cells die through a newly identified form of cell death known as cuproptosis. “We’ve uncovered a fun

Peter Mac's Dr Jamie Kuzich has received the American Society of Hematology (ASH) 2024 Global Research Award - one of just of 11 awarded to early career investigators from around the globe. Dr Kuzich, a clinical haematologist completing the final year of his doctoral studies in Professor Mark Dawson's lab, will use the funding to further explore his project into improving chimeric antigen receptor (CAR) T cell therapy using sophisticated tools to identify, trace and profile "persister cells" tha